Bdhi.Bo

BDHI maintains a strong liquidity position, with a current ratio of 3.95, indicating the company can easily cover its short-term liabilities with its current assets. The company's liquidity_fpt score is high, supported by a cash and equivalents balance of INR 298.28 million, which is a significant portion of its total assets. This liquidity provides BDHI with flexibility in managing its operations and capital expenditures.

In terms of profitability, BDHI's return on equity (ROE) of 13.49% and return on assets (ROA) of 10.67% are both above the industry median for pharmaceutical companies, suggesting efficient use of equity and assets to generate profits. The company's operating margin, calculated as operating income of INR 107.01 million on revenue of INR 665.08 million, is also in line with industry norms, indicating a healthy balance between cost control and revenue generation.

BDHI's revenue is primarily concentrated in its domestic market, with no disclosed international operations in the latest financial data. The company's business is not segmented by product or geographic region in the available data, but its revenue concentration suggests a reliance on the Indian pharmaceutical market. This concentration could expose the company to regulatory and economic risks specific to the region.

Looking at growth, BDHI's revenue for the latest period was INR 665.08 million. While the outlook for the current fiscal year is stable, the company has not disclosed specific growth targets or projections for the next fiscal year. The absence of a clear growth trajectory makes it difficult to assess the company's long-term expansion plans.

Risk factors for BDHI are currently low, with no immediate liquidity or dilution concerns identified. The company's debt-to-equity ratio is 0.01, indicating minimal leverage and a conservative capital structure. However, the lack of disclosed capital expenditures beyond INR 2.15 million suggests limited near-term investment in growth or expansion. The company's dilution potential is also low, with no recent or pending share issuance activities reported.

Recent events for BDHI include the latest financial filing, which shows a stable financial position with no significant changes in operations or strategy. The company has not issued any new products or entered into major partnerships in the disclosed period. The absence of recent strategic moves or product launches may indicate a focus on maintaining current operations rather than pursuing aggressive growth.